Professional
Added to YB: 2025-06-23
Pitch date: 2025-04-24
FTRE [neutral]
Fortrea Holdings Inc.
+165.99%
current return
Author Info
No bio for this author
Company Info
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Market Cap
$961.9M
Pitch Price
$5.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
85.02
P/E
-0.92
EV/Sales
0.73
Sector
Life Sciences Tools and Services
Category
turnaround
Prosper Stars & Stripes Portfolio Holding: Fortrea Holdings Inc. (short)
FTRE closed short: CRO spinoff from LabCorp struggled with high debt (5.1x leverage), lower metrics vs peers (revenue/FTE, R&D ROI, 50% lower margins). Q4 guidance disappointed at -7% growth, 7.5% EBITDA margin vs expected positive growth and double-digit margins. Position closed after price decline.
Read full article (1 min)